Horizon Pharma reported $326.54M in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 3179M 2413M
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Aerie Pharmaceuticals AERI:US $ -39.69M 1M
ALKERMES ALKS:US $ -28.99M 31.35M
Amgen AMGN:US $ 1884M 1420M
AstraZeneca AZN:LN -1652M 2202M
Bristol Myers Squibb BMY:US $ 1546M 491M
Coherus Biosciences CHRS:US $ -38.53M 8.63M
Eli Lilly And LLY:US $ 1110.1M 280.1M
Endo International Ordinary Shares ENDP:US $ -77.21M 61.71M
Flexion Therapeutics FLXN:US $ -30312000 8.1M
Horizon Pharma HZNP:US $ 326.54M 168.43M
JAZZ PHA JAZZ:US $ -52.83M 310.48M
Merk MRK:US $ 4567M 3022M
Novartis NOVN:VX SF 2758M 138M
Pacira Pharmaceuticals PCRX:US $ 17.66M 1.42M
Perrigo Ordinary Shares PRGO:US $ -58.9M 1.2M
Pfizer PFE:US $ 8146M 2582M
Prestige Brands PBH:US $ 45.32M 12.43M
Revance Therapeutics RVNC:US $ -74.38M 2.18M
Supernus Pharmaceuticals SUPN:US $ 21.56M 2.16M
Takeda 4502:JP Y 45965M 154412M
Teva Pharmaceutical Industries TEVA:US $ 290M 83M
Valeant Pharmaceuticals VRX:CN $ 188M 783M
Xeris Pharmaceuticals Inc XERS:US -26009000 1.51M
Zoetis ZTS:US $ 552M 40M